SCHEMBL24801583

SCHEMBL24801583

Cn1cc(-c2cc3ccc(N4CCCCC4)cc3nc2N)c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 3/20 0.48
▸ DHFR P00374 1/20 0.41
▸ CDK5 Q00535 2/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ RET P07949 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ CDK7 P50613 1/20 0.40
▸ LIMK1 P53667 1/20 0.40
▸ PTK2 Q05397 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ LRRK2 Q5S007 1/20 0.40
▸ AURKB Q96GD4 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30720821 1.00 TERT (0.48) TERTDHFRCDK5PDK1AURKA
SCHEMBL29158066 0.91 EGFR (0.47) DHFREGFRALDH1A1KDM4ENPC1
SCHEMBL30720818 0.91 EGFR (0.47) DHFREGFRALDH1A1KDM4ENPC1
SCHEMBL24800587 0.89 DHFR (0.43) DHFRCDK5PDK1AURKAJAK2
SCHEMBL29157692 0.86 DHFR (0.46) DHFRCDK5PDK1AURKAJAK2
SCHEMBL29157760 0.86 DHFR (0.41) DHFRCDK5PDK1AURKAJAK2
SCHEMBL30720819 0.86 DHFR (0.46) DHFRCDK5PDK1AURKAJAK2
SCHEMBL24800573 0.85 DHFR (0.41) DHFRCDK5PDK1AURKAJAK2
SCHEMBL30720823 0.85 DHFR (0.41) DHFRCDK5PDK1AURKAJAK2
SCHEMBL29157712 0.85 DHFR (0.41) DHFRCDK5PDK1AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117597125-A Indole-substituted quinolines and their use in combination with PLK1 inhibitors for the treatment of cancer 肯塔基大学研究基金会 2024-02-23 — — CN disclosed
WO-2022271676-A1 INDOLE-SUBSTITUTED QUINOLINES AND THEIR COMBINATION WITH PLK1 INHIBITORS FOR THE TREATMENT OF CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2022-12-29 — — WO disclosed
Send feedback